Annual Report for the Financial Year 2025-26 including Notice of 33rd Annual General Meeting of the Company to be held on 30.09.2026.

lsHITA DRUGS & INDUSTRIES LTD. Corp. Off* 401, 3rd E)re 11, Opp. Parimal Garden, C. G. Road, Ahmedahad-380006. Regd. OfRce & F:actory : 179/I, Vlsna-lya`ra, Tat. Sanand, Disc. . Ahmedabad. E-mall : ichitadrues®rmail.com I info®ishitadrufs.com I URL : www.ishitadrues.com Phone : +917226995613/14/15 I +9179 4002 3839 Date: - Z7.08.ZOZ6 Department of Corporate Services, BSE Limited. Floor No. 25, Phiroze )eejeebhoy Towers, Dalal Street, Mumbal-400 001 Scrii] Code: - 524400 Ira Sir/Madani, Suub:SubmissionofAnnualReDortfortheFilranciaLYear2025-26 Pursuant to the provisions of Regulation 34 of the SEBI (LODR) Regulations, 2015 we are enclosing herewith Annual Report for the Financial Year 2025-26 along with the Notice of 33rd Annual General Meeting (AGM) Of the Company to be held on Wednesday, 30th September, 2026. TThe same is also available on the Company's website at www.ishitadrugs.com Thanking yo u. For, [shita Drugs and Industries Limited. ]agdish Agrawal Managing Directo r DIN: 01031687 •Ou:I basic dxpgs in the seTihee Of hunonrty =i;ondfundt n CIN No. L24231GJ1992PLC017054 D a a D-U-N-S Number -65J)18-0359 ISHITA 33 Annual Report 2025-26 Ishita Drugs & Industries Limited “Our basic drugs in the service of humanity worldwide” ISHITA DRUGS AND INDUSTRIES LTD. 33rd ANNUAL REPORT 2025-26 THIRTY­ THIRD ANNUAL REPORT ­ 2025­26 Board of Directors : Mr. Jagdish Agrawal - Managing Director [DIN: 01031687] Mrs. Abha Agrawal - Director [DIN: 01589479] Mr. Arvind Sapkal - Director [DIN: 08607096] Ms. Dhwani Solanki - Director [DIN:10299290] Chief Financial Officer : Mr. Sumit Agrawal Bankers : Union Bank ICICI Bank Ltd. Punjab National Bank Auditors : M/s. Jaymin Shah & Associates Chartered Accountants, Ahmedabad. Secretarial Auditor : M/s. Meenu Maheshwari & Associates Practicing Company Secretaries Ahmedabad Corporate Office : 401, 3rd EYE -II, Opp.Parimal Garden, C.G.Road, Ahmedabad - 380 006. Registered Office & : Survey No. 179/1, Village : Vasna-Iyava, Factory Taluka : Sanand, District : Ahmedabad Website : www.ishitadrugs.com Investors' Complaints may : Ms. Srushti Pandya be addressed to Company Secretary and Compliance Officer at Corporate office. E-mail: investors@ishitadrugs.com ANNUAL GENERAL MEETING On Wednesday, 30th September,2026 at 11.30 A.M. ISHITA DRUGS AND INDUSTRIES LTD. 33rd ANNUAL REPORT 2025-26 NOTICE TO THE SHAREHOLDERS 2014 and Section 152 of the Companies Act, 2013, and based on the recommendations of the Nomination and Notice is hereby given that the THIRTY-THIRD (33RD) Remuneration Committee and the Board of Directors of ANNUAL GENERAL MEETING of the Members of ISHITA the Company, Mrs. Abha Agrawal (DIN: 01589479), DRUGS AND INDUSTRIES LIMITED (CIN: who retires by rotation and being eligible offers herself L24231GJ1992PLC017054) will be held on Wednesday, 30th for re-appointment, and who has attained the age of 75 September, 2026 at 11.30 a.m. at “Manthan”, Hotel Krsna years, be and is hereby re-appointed as a Non- Lila, Nr. Rexroth Bosch, Village Iyava, Taluka Sanand, Executive Non- Independent director of the Company Sanand Viramgam Highway, Gujarat 382170 to transact post attaining the age of 75 years, liable to retire by the following business: rotation.” ORDINARY BUSINESS: “RESOLVED FURTHER THAT Board of Directors of the Company be and are hereby authorized to file all To consider, and if thought fit, to pass, all the following necessary e-forms with the Registrar of Companies and resolutions as an Ordinary Resolution: to do all such acts, deeds, matters and things and take all such steps as may be considered necessary, proper 1. To receive, consider and adopt the Audited Financial or expedient to give effect to this resolution.” Statements of the Company for the Financial Year ended 31st March, 2026 together with the Reports of 4. To approve the Related party transactions with Board of Directors and Auditors thereon. Ishita Pharmaceuticals: 2. To consider the re-appointment of M/s Jaymin Shah & To Consider and, if thought fit, to pass with or without Associates, Chartered Accountants (FRN No. modification, the following resolution as an Ordinary 129406W) as the Statutory Auditors of the Company for Resolution: a period of one year: “RESOLVED THAT pursuant to the provisions of “RESOLVED THAT pursuant to the provisions of Section 188 of the Companies Act, 2013 read with Rule Section 139, 142 and other applicable provisions, if any, 15 of the Companies (Meetings of Board and its of the Companies Act, 2013 and rules framed there Powers) Rules, 2014 and Regulation 23 of the SEBI under, as amended from time to time, the Company (Listing Obligations and Disclosure Requirements) hereby appoints M/s. Jaymin Shah & Associates, Regulations, 2015, and other applicable Regulations, if Chartered Accountants (FRN No. 129406W) as the any [including any amendment(s) and statutory Statutory Auditors of the Company to hold office from modification(s) thereof, for the time being in force], and the conclusion of this (33rd) Annual General Meeting till on the basis of approval and recommendation of the the conclusion of the next (34th) Annual General Audit Committee and the Board of Directors of the Meeting of the Company on such remuneration plus Company, approval of the Members of the Company be applicable taxes, out-of-pocket expenses, etc. as may and is hereby accorded to the Company for entering be mutually agreed between the Board of Directors of into and/or carrying out and/or continuing with the the Company and the Auditors.” existing contract(s)/ arrangement(s)/ transaction(s) or modification(s) of earlier / arrangement(s)/ SPECIAL BUSINESS: transaction(s) or as fresh and independent transaction(s) or otherwise, regarding to sales, 3. To approve re-appointment of Mrs. Abha Agrawal purchase or supply of goods or materials, leasing of (DIN 01589479) as a Non-Executive Non- property of any kind, availing or rendering of any Independent Director of the Company post attaining services including the providing or receiving of loans or the age of 75 years, and who retires by rotation, guarantees or securities or making investments, being eligible offers herself for re-appointment. (whether individually or series of transactions taken together or otherwise) with ISHITA To consider and if thought fit, to pass with or without PHARMACEUTICALS, a “Related Party” of the modification(s), the following resolution as a Special Company as per Section 2(76) of the Act, and Resolution: Regulation 2(1)(zb) of the SEBI Listing Regulations, may exceed 10% of the annual turnover of the “RESOLVED THAT pursuant to Regulation 17(1A) of Company, as per last audited financial statement, in a Securities and Exchange Board of India(Listing financial year or such other threshold limits as may be Obligations and Disclosure Requirements) specified by the SEBI (LODR) Regulations from time to Regulations, 2015 (including any statutory time, however, that the said contract(s)/ arrangement(s) modification(s) or re-enactment thereof, for the time / transaction(s) shall be carried out at an arm's length being in force) and applicable provisions, if any, of the basis and in the ordinary course of business of the Companies Act, 2013 read with Companies Company.” (Appointment and Qualification of Directors) Rules, ISHITA DRUGS AND INDUSTRIES LTD. 33rd ANNUAL REPORT 2025-26 “RESOLVED FURTHER THAT Board of Directors of the Notes Company be and is hereby authorized to do all acts, a) A member entitled to attend and vote in the meeting deed, matters or things and take all such steps as may is also entitled to appoint one or more proxies to be necessary, proper and expedient to give effect to this attend and vote instead of him and not later than 48 resolution.” hours before the time fixed for holding the meeting. b) Members are requested to advise immediately any 5. To approve the Related party transactions with Anvi change in their address to the Company. Lifesciences Private Li [Showing first 8,000 characters — download PDF for full document]